The objective of this study was to explore the interrelationship between intentional and unintentional non-adherence vis-à-vis patients' medication beliefs. METHODS: We conducted a cross-sectional survey of adults with asthma, hypertension, diabetes, hyperlipidemia, osteoporosis, or depression from the Harris Chronic Disease Panel. A total of 24,071 adults self-identified themselves as currently persistent to prescription medications for their index disease. They answered three questions on unintentional non-adherence, 11 questions on intentional non-adherence, and 20 questions assessing their beliefs about the index medication, which generated multi-item scales assessing perceived medication need (kϭ10), perceived concerns (kϭ6), and perceived affordability (kϭ4).The regression approach proposed by Baron and Kenny was used to test the mediational effect of unintentional non-adherence on the relationship between medication beliefs and intentional non-adherence. Bootstrapping was also employed to confirm the statistical significance of these results. RESULTS: It was hypothesized that the effect of medication beliefs (perceived need, concerns, and affordability) on intentional non-adherence is mediated through unintentional non-adherence. The four conditions outlined by Barron and Kenny for a variable to be considered as a mediating variable were satisfied. The three medication beliefs had a significant direct effect on unintentional non-adherence. The direct effect of unintentional non-adherence on intentional non-adherence was significant as was the total effect of medication beliefs on intentional non-adherence. The impact of medication beliefs on intentional non-adherence was reduced after controlling for unintentional non-adherence. The statistical significance of the mediational relationship was confirmed using the bootstrapping procedure with 5,000 samples. CONCLUSIONS: Unintentional non-adherence may appear to be a rather benign behavior; however, its importance may lie in its potential prognostic significance for future intentional non-adherence. Hence, health care providers should screen for unintentional non-adherence in patients while they are still on therapy and proactively address suboptimal medication beliefs that might ultimately lead the patient to discontinue therapy.
OBJECTIVES:
Over the past two decades use of the traditional paper-and-pencil survey has waned as options for electronic data collection have been shown to be rigorous and more cost-effective. Although research supports equivalence of paper and electronic administration modes, evidence examining the impact of changes in item form required to accommodate small format electronic devices is lacking. This study examined the impact of a single item (SI) presentation versus grid display (GD) for score equivalence, measurement properties and adherence to the conceptual framework of the SF-36v2. METHODS: The SF-36v2 standard recall form was electronically presented as part of a US national norming study. Survey results from SI (Nϭ2037) and GD (Nϭ2003) administrations were then scored. ANCOVA models compared SI and GD scale scores. A Multi-trait Analysis Program (MAPR) and principal components analysis (PCA) were used to examine the measurement properties and test the conceptual framework of SI and GD data. RESULTS: Mean score comparisons revealed small differences between SI and GD on seven scales (all pϽ 0.01). Mean differences (.43 to 1.42), however, failed to reach the minimally important difference of 3 points indicating relative equivalence. MAP-R analyses showed that, for both item formats, SF-36v2 items had excellent convergent validity with their hypothesized scale (rϾ0.4) and each item correlated higher with its hypothesized scale than with others (divergent validity). PCA results showed that the hypothesized two-dimensional structure of physical and mental health was evident in both formats as the pattern of correlation between scales and principal components was consistent with a priori hypotheses and the two components explained the majority of variance in the eight scales (Ͼ75%). CONCLUSIONS: Single item presentation, which separates items from the contextual cues of their traditional grid format, results in scores and measurement properties consistent with GD, and maintains the underlying conceptual framework of the SF-36v2. Ying X, Khandelwal N, Korcheck R, Duncan I Walgreens, Deerfield, IL, USA OBJECTIVES: To determine the value of a web portal by quantifying the differences in medication adherence between web-users and non-web-users. METHODS: A case-control study design was employed for this study. Prescription records from a de-identified pharmacy claims database maintained by a large pharmacy benefit manager were obtained between April 1 st 2009 to March 31 st 2010. The test group consisted of patients who filled their prescriptions via a web-based portal. Patients who were enrolled in similar health plans but never used the web portal to fill their prescriptions comprised the control group. All eligible patients included in this analysis were continuously enrolled during the study period. Differences in medication possession ratio (MPR), defined as the sum of days that patient possessed any maintenance medication divided by the total number of days in the follow-up period, was calculated during the observation period and compared using a paired t-test. Additionally, MPRs for the Top 10 therapeutic medication classes were computed and compared across test and control group. RESULTS: A total of 2,333,635 eligible patients were included in the study. Among them 53,018 patients met the criteria for test group and 2,280,617 patients were included in the control group. Overall mean MPR for the test group was found to be significantly higher (0.48 Vs 0.37) as compared to the control group (pϽ0.05). Additionally, across all the Top 10 medication classes, the test group patients'mean MPR was significantly higher than that of control group patients. CONCLUSIONS: Patients, who filled their prescriptions via the web portal, have higher adherence rates as compared to those who do not choose this channel to fill their scripts. Further studies aimed at evaluating key drivers for the differential adherence rate are required to gain additional insights about the importance of web-portal as a tool for refilling prescriptions. 
PRM26

IMPACT OF A WEB PORTAL TOOL ON DRIVING PATIENT ADHERENCE
OBJECTIVES:
To comprehensively search for SF-12 utility scorings and for EQ-5d scorings that can be applied to SF-12 data converted to EQ-5d responses using Gray's (2006) algorithm. To apply quality/dominance criteria to the identified scorings, apply the scorings of good quality to 3 large US data sets that used the SF12, and examine the implications for scoring strategy. METHODS: A Medline search and hand search of selected journals and of reference lists in relevant articles yielded 27 EQ-5d scorings and 18 studies that provided 29 SF12/SF36 scorings. Quality/dominance criteria excluded 16 scorings from 8 studies. Data sets scored included a survey of 21,564 disabled veterans, a national probability sample of 20,048 veterans, and a longitudinal survey with 4,600 responses from 1,547 hospital-admitted burn victims. We averaged subsets of scores, weighting each component score by the number of people polled in the utility weighting exercise. We also scored 5 extreme value cases. RESULTS: The composite score performed quite well. Its values and distribution were similar to those in Sengupta's Health Utility Index 3 scoring and Lawrence's scoring derived from SF-12 domain scores. Much has been made of the Shaw article that purportedly shows that EQ-5d scoring needs to be country specific. That article used a different scoring equation than other EQ-5d scorings. Its scores differ as much from 4 other US scorings as from overseas scorings -and the other US scores are concordant with the overseas scores. The Gray algorithm performed extremely well, especially when supplemented by questions on use of mobility aids. SF-12 scorings are less dispersed and more prone to floor and ceiling effects than EQ-5d scorings. Time-tradeoff EQ-5d scorings have higher variance than visual-analog scorings. CONCLUSIONS: Some scorings are better than others, with Sengupta or Lawrence recommended. Country of origin rarely matters, with some possible exceptions (Hispanic, African American).
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CREATION OF A NEW PSORIASIS QUALITY OF LIFE MEASURE FROM FIVE PREEXISTENT INSTRUMENTS USING RASCH ANALYSIS: THE CALIPSO QUESTIONNAIRE
Sampogna F 1 , Styles I 2 , Tabolli S 1 , Abeni D 1 1 Istituto Dermopatico dell'Immacolata IDI-IRCCS, Rome, Italy, 2 The University of Western Australia, Perth, Australia OBJECTIVES: To create a new instrument to evaluate quality of life (QoL) in patients with psoriasis, from five preexistent instruments, using Rasch analysis. METHODS: A Rasch analysis was performed on five QoL instruments, in a group of 936 patients with psoriasis, recruited in a dermatological hospital. Two instruments were dermatology-specific [Skindex-29 and Dermatology Life Quality Index (DLQI)], and three were psoriasis-specific [Psoriasis Disability Index (PDI), Psoriasis Life Stress Inventory (PLSI), and Impact of Psoriasis questionnaire (IPSO)]. The total number of items was 85. The number of categories was reduced to three in each instrument on the basis of threshold probability curves. Having identified threshold and item performance for each scale separately, items from all five scales were analyzed together. Items were eliminated on the basis of poor fit to the model, dependencies amongst items, item location and qualitative meaning of the items, with the overall goals of obtaining a uniform and wide spread of the items as possible, and a balance among the different subscales. RESULTS: We obtained a final questionnaire of 30 items: 4 symptom, 9 emotion, 10 functioning, and 7 social items. Fifteen out of 29 items came from the Skindex-29, 8 from the PLSI, 3 from the IPSO, 2 from the DLQI, and 2 from the PDI. The fit of these items to the Rasch model was satisfactory. The final Person Separation Index (PSI) was 0.916. CONCLUSIONS: The advantages of this new instrument are that data for it fit the Rasch model, and that it summarizes information from five questionnaires (i.e., 85 items) with just 30 items. Moreover, the 30-item questionnaire is working better than the five instruments together, as the properties we analyzed show. The new instrument will be validated on a new sample of 300 patients with psoriasis.
PRM29 METHODOLOGICAL DIFFERENCES IN EQ-5D SCORING SYSTEMS: A SYSTEMATIC REVIEW AND ANALYSIS
spread use of the EQ-5D a number of country-specific scoring systems have been developed. The objective of this study was to identify and compare all existing EQ-5D valuation studies and country-specific scoring systems. METHODS: An electronic search of MEDLINE, EMBASE, NHS EED, HEED and a search through the past proceedings of the Euroqol group up to September of 2010 was conducted to identify all EQ-5D preference elicitation studies. The review included a summary and comparison of study design, model estimation, study demographics and scoring function. RESULTS: After screening 2940 citations identified from the literature search, 33 elicitation studies that contained a unique scoring system were included for final review. The key areas of divergence between the studies include: differences in methodology used to directly value health (i.e. SG, TTO, etc.), the number of health states that were directly valued, the transformation of the directly valued health states, the statistical methods used to derive the scoring system, and the model variables included in the scoring system. CONCLUSIONS: Differences in methods do exist between population studies. Knowing the extent, at which the identified methodological differences can explain the variation, will help determine whether a global preference for health exists. 
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RESULTS FROM A NEW VISUAL ANALOGUE SCALE PROTOCOL FOR EQ-5D VALUATIONS
OBJECTIVES:
The MVH protocol uses a valuation subset of 43 EQ-5D states. Smaller valuation subsets would allow smaller samples if all respondents can value one set of states. This study tests the performance of valuation subsets based on orthogonal experiment designs. VAS values obtained for EQ-5D states are affected by the identity of adjacent states in the elicitation. This study also tests a VAS protocol developed to minimize such effects. METHODS: 230 respondents were each randomly assigned to one of two orthogonal EQ-5D valuation subsets. EQ-5D states were printed on 9cm x 4cm cards with rhomboid edges. Respondents first ranked a shuffled deck of 23 cards. A 1 meter VAS was then placed next to the ranked cards. Respondents transferred the cards on to the VAS with the rhomboid edges pointing to the respective values. They could see all of the cards in place at the same time. Ties were permitted and respondents were free to change the order of states in moving the cards from the ranked order to the VAS. RESULTS: OLS regression of VAS Scores produced internally valid models for both valuation subsets with r 2 of 0.54 and 0.56. Within sample comparisons of model versus observed VAS values produced residuals of MAD Ͻ 3% with individual values crossing 6 VAS points in only 2 cases. Rank correlation coefficients between model and observed states ϭ0.996. Comparisons across the two subsets/subgroups produced residuals of MADϭ4 VAS points and rank correlation coefficients of 0.98 and 0.96. CONCLUSIONS: This study suggests that orthogonal experiment designs may be suitable as the basis for the construction of EQ-5D valuation subsets, which can allow for smaller respondent samples. The statistical properties of the models arising in this study suggest that some concerns with VAS methods for EQ-5D elicitations may be reduced using this protocol.
PRM32 VALIDITY EVIDENCE AND VALIDATION PRACTICE IN PAPERS PUBLISHED IN VALUE IN HEALTH (1998-2010): A SYSTEMATIC REVIEW
Chan EKH 1 , Darmawanti I 2 , Mulyana OP 2 , Zumbo BD 1 1 University of British Columbia, Vancouver, BC, Canada, 2 State University of Surabaya, Surabaya, East Java, Indonesia OBJECTIVES: Patient-reported outcome (PRO), health-related quality of life (HRQOL), and related instruments are increasingly used in outcomes research. In developing and evaluating PRO, HRQOL, and related instruments, measurement validity is a fundamental consideration. With an eye toward investigating the methodology of validity and uses of validation, we systematically reviewed the reporting of validation practice in papers published in Value in Health, the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) official journal. METHODS: A systematic search using the journal official website was conducted in December 2010 -including papers since its inception (January 1998) to December 2010. Two searches were independently conducted by two of the authors. Keywords used in the search included "development OR measurement OR psychometric OR psychometrics OR valid OR validation OR validity." We searched both the titles (126 citations) and abstracts (347 citations). Papers reporting empirical results on validity were included. Econometric, opinion, and conference papers were excluded. A coding sheet was developed and each article was double-coded independently by at least two of the authors. RESULTS: Ninety-three articles met the inclusion criteria. The percentage of reports of the broad categories of validity evidence were: construct (39.8%), discriminant (28.0%), convergent (26.9%), content (17.2%), concurrent (14.0%), predictive (5.4%), response processes (4.3%), and consequences (1.1%). A paper may report more than one type of validity evidence. In addition, 95.7% of the papers referred to the validity of the instrument, rather than the modern view of validity of the inferences from the scores. CONCLUSIONS: Findings reveal that validity information is not routinely presented from a modern validity perspective; that is, consider a unitary view of validity, cite recent theoretical papers in validity theory, or distinguish between validity (as a property) and validation (as a process/method). Some sources of validity evidence (e.g., consequences and response processes) are essentially ignored.
PRM33 TAKE TIME TO TRAIN: EVIDENCE TO SHOW THAT PATIENT TRAINING IN ELECTRONIC PATIENT REPORTED OUTCOMES IS BENEFICIAL
Ross J 1 , Ross E 1 , O'Gorman HJ 2 , Peck R 1 1 Almac Clinical Technologies, Souderton, PA, USA, 2 Almac Group, Craigavon, UK OBJECTIVES: To establish the concept that it is best practice to provide training to patients on how to utilize electronic patient reported outcome (ePRO) systems before patients begins study participation. METHODS: Methods on how to approach training patients on ePRO systems will be presented and recommendations will be discussed. To provide supporting evidence and information on best practices used in ePRO, a literature review was conducted to identify articles reporting on studies that utilized ePRO. Of that, articles were identified that reported providing training to their patients on the ePRO portion of the study prior to participation. Rates of ePRO compliance are examined and approaches to training patients are identified within the articles. RESULTS: Out of the 115 articles identified using ePRO, 55 (47.8%) reported providing ePRO training to their patients. ePRO compliance rates of studies with patient training were overall high (Meanϭ85.08, Standard Deviationϭ9.83). Training methods reported included: training session, providing demonstration, giving instruction, question/answer session, subject hands-on practice, written instructions/reference material, and testing of mastery of ePRO tool. Duration of training reported ranged from 1 minute to 4 hours. CONCLUSIONS: Best practice for training patients is to have a combination of the methods reported above. Having available a dummy system for training is most important so that demonstration can be provided, patients can practice using the system and patients can see exactly what they need to do during their actual study participation. Questions can be addressed and patients can begin the study with a clearer understanding of what to do during participation. Training patients allows for higher comfort levels in use of system, thus alleviating frustration and burden. Furthermore, when patients are trained, they require less support throughout the duration of the study. Overall, training patients will lead to better experiences for patient participation. Medicine, Cincinnati, OH, USA, 3 Pfizer, Inc., New York, NY, USA, 4 RTI Health Solutions, Ann Arbor, MI, USA OBJECTIVES: Assessments composed of patient-reported outcome (PRO) measures can be used in health care settings as screeners for various conditions. The objective of developing and using a PRO screening measure may be to quickly identify patients who are likely to benefit from a formal diagnostic evaluation. Alternatively, the development objective may be to avoid unnecessary diagnostic procedures, particularly when these are time or resource-intensive or invasive in nature. The PRO screener may also be administered to simply rule out the existence of a particular condition. The evaluation of a PRO screening assessment ideally occurs through analyses using a "gold standard" diagnosis of the condition of interest. METHODS: A number of existing statistical and psychometric methods may be used in such an evaluation, including sensitivity and specificity, positive and negative predictive value, kappa, accuracy, odds ratio, and likelihood ratio. RESULTS: The evaluation method selected depends on the objective of the screener itself. If the formal diagnostic procedures are particularly invasive or time-or resourceintensive, then screeners should minimize false positives; in contrast, diseases with exceptional risks when left undiagnosed call for screeners that minimize false negatives. In this research, we explore these methods using data from a study comparing various fibromyalgia screening instruments with the currently accepted gold standard diagnosis for fibromyalgia, namely the American College of Rheumatology 1990 diagnostic criteria (Wolfe et al., 1990) . CONCLUSIONS: Using the example application, we illustrate the pros and cons of a battery of statistical methods and how they can be used to select the "best" candidate screener.
PRM34 EVALUATING THE SCREENING ABILITY OF PATIENT-REPORTED OUTCOME INSTRUMENTS
PRM35
DEVELOPMENT OF A CONCEPT LIST TO ENSURE COMPARABLE CONTENT VALIDITY BETWEEN ORIGINAL PRO QUESTIONNAIRES AND THEIR TRANSLATIONS: A REVIEW OF 15 YEARS OF LINGUISTIC VALIDATIONS
Mear I 1 , Conway K 2 1 MAPI Institute, Lyon, France, 2 MAPI Research Trust, Lyon, France OBJECTIVES: In its guidance on the use of PRO measures, the FDA recommends that sponsors provide evidence that the content validity and other measurement properties are adequately similar across all versions used in a clinical trial. One way to ensure the comparability of content is to ensure that all translations reflect the original item intent. As this presupposes the existence of a formal description of each item concept, it is the objective of this study to investigate if this was the case prior to the guidance publication and to make recommendations on the basis of our findings. METHODS: The research is based on the review of PRO translations performed between 1995 and 2009. RESULTS: A total of 640 questionnaires (27 generic and 613 disease-or condition-specific) were translated. All were developed before the publication of the FDA's PRO guidance. None had a formal written document listing a definition of each item concept and possible translation alternatives available before launching the translations. In all cases, the item-by-item concept list and the list of translation alternatives were developed in collaboration with the developers of the original questionnaires during the translation process. In some cases (multiple projects involving different languages for the same questionnaire), the development of the concept list was a dynamic process fed by questions raised at each new translation [e.g. Quality of Life in Inflammatory Bowel A151
